Evommune, Inc. (BX:EVMN) Financings

Evommune, Inc.

Financings

RaiseDate
Private placement of common stock
Announced: about US$125M · US$27.88 a share · Morgan Stanley & Co. LLC +5
Dealers: Morgan Stanley & Co. LLC, Leerink Partners LLC, Evercore ISI, Cantor Fitzgerald & Co., William Blair & Company, L.L.C., Oppenheimer & Co. Inc.
Use of proceeds: To advance its clinical development programs and for general corporate purposes
Feb 13, 2026
Public offering of common stock
Update: US$150M · US$16 a share · Morgan Stanley +3
Dealers: Morgan Stanley (co-lead), Leerink Partners (co-lead), Evercore ISI (co-lead), Cantor (co-lead)
Nov 6, 2025

Read by 6ix AI from the company's releases